Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: J Thorac Oncol. 2010 Mar;5(3):380–384. doi: 10.1097/JTO.0b013e3181cee36e

Table 3.

Grade 3 Treatment Related Adverse Events (n=44)

Number %
Hematologic
 Hemoglobin 1 2%
 Lymphocytes 1 2%
Non-hematologic
 Fatigue 6 14%
 Pleural effusion 5 11%
 Pericardial effusion 3 7%
 Nausea 2 5%
 Vomiting 2 5%
 Anorexia 1 2%
 Diarrhea 1 2%
 Abdominal pain 1 2%
 Rash/desquamation 1 2%